Health News Releases

  • Today May 20
June 08, 2016 17:20
Pooled Data from Meta-Analysis Suggest Significant Overall Survival Benefit of Investigational REVLIMID® Maintenance Following Autologous Stem Cell Transplant in Multiple Myeloma
Celgene Corporation (NASDAQ:CELG) today announced data from a meta-analysis of overall survival in multiple myeloma (MM) patients receiving investigational maintenance treatment with REVLIMID® (lenali
June 08, 2016 13:45
Final Subject Enrolled in Early Feasibility Study of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
W. L. Gore & Associates, Inc. (Gore) today announced completion of enrollment into its early feasibility study evaluating the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE) for the tre
June 08, 2016 11:15
Win a Fishing Trip with President Jimmy Carter by Committing to Zero Preventable Deaths by 2020
The Patient Safety Movement announced today that for the 2nd year in a row, former President Carter is demonstrating his support for the Movement’s goal of zero preventable deaths by 2020 by offering
June 08, 2016 09:55
Boehringer Ingelheim and Harvard scientists establish a research alliance to find novel treatments for severe fibrotic diseases
Boehringer Ingelheim today announced it has established a research collaboration with the Harvard Stem Cell Institute’s - Harvard Fibrosis Network to discover new ways of treating fibrotic diseases su
June 07, 2016 11:45
New data on olmutinib (BI 1482694) presented at ASCO 2016 underscores clinical potential of Boehringer Ingelheim’s next generation lung cancer compound
Boehringer Ingelheim will announce updated results from the Phase II part of the HM-EMSI-101 [NCT01588145] trial at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, U
June 03, 2016 17:45
Herbalife Returns as Title Sponsor of Bali International Triathlon 2016
Herbalife, a global nutrition company (NYSE: HLF), announced today that it has become the title sponsor of the Bali International Triathlon 2016. Now officially named the Herbalife Bali International
June 03, 2016 14:20
Quintiles Introduces Precision Enrollment to Enhance Patient Recruitment in Oncology Trials
Quintiles, the world’s largest provider of product development and integrated healthcare services, today announced its Precision Enrollment offering. The new enrollment model is designed to significan
June 03, 2016 13:30
One of India’s Premier Maternal Care Specialists, Motherhood Hospitals, Standardizes on Masimo SET® Technology
Masimo (NASDAQ: MASI) announced today that Motherhood Hospitals, a maternal care specialist with five hospitals in three cities in India, has standardized on Masimo SET® (Signal Extraction Technology)
June 03, 2016 13:15
GORE® EXCLUDER® Conformable AAA Endoprosthesis Obtains CE Mark
W. L. Gore & Associates, Inc. (Gore) today announced receipt of CE Mark for the GORE® EXCLUDER® Conformable AAA Device, a product designed for the treatment of abdominal aortic aneurysms (AAA) in pati
June 03, 2016 11:50
Boehringer Ingelheim launches ambitious ELUXA trial programme to broadly investigate promising lung cancer compound olmutinib
Boehringer Ingelheim has initiated the ELUXA trial programme, designed to further investigate the therapeutic potential of olmutinib* (BI 1482694 / HM61713), a novel third-generation, epidermal growth
June 02, 2016 16:55
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) as Consolidation Treatment in Post-Transplant Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for th
June 01, 2016 19:00
Worldwide Innovative Networking (WIN) in Personalized Cancer Medicine is Very Proud to Announce That Institut Curie, France Has Joined Its Consortium
“We are very proud to welcome Institut Curie to WIN,” said Dr. John Mendelsohn, Chairman of WIN and Director of the Khalifa Institute for Personalized Cancer Therapy and past President of MD Anderson
May 31, 2016 18:45
Boehringer Ingelheim and Inventiva collaborate to develop potential new treatments for idiopathic pulmonary fibrosis
Boehringer Ingelheim and Inventiva, a French biopharmaceutical company specialised in the development of innovative therapies for fibrosis, oncology and orphan diseases, announced today, a new multi-y
May 30, 2016 13:55
Samsung Bioepis Becomes First to Obtain European Commission Approval for Second Anti-TNF-α Biosimilar with Flixabi®
Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Flixabi® - a biosimilar version of Remicade® (infliximab), also known as SB2 - for the treatment of rheumatoid arth
May 30, 2016 11:40
Takeda Provides Update on EU Marketing Authorization Application for NINLARO® (ixazomib) in Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a negative opinion, recom
May 27, 2016 14:20
Masimo to Showcase Next Generation SedLine® Brain Function Monitor at 2016 Euroanaesthesia Congress
Masimo (NASDAQ: MASI) announced today the CE mark and scheduled full market release of Next Generation SedLine® Brain Function Monitoring technology at the European Society of Anaesthesiology’s (ESA)
May 27, 2016 13:05
3 out of 4 people with symptomatic asthma report reduced productivity at work
Not for distribution to UK/US/Canadian media Results were released today by Boehringer Ingelheim from an international survey, providing new insight into the negative impact of persistent asthma sy
May 26, 2016 16:40
Sumitomo Heavy Industries Announces Samsung Medical Center Starts Proton Therapy
Sumitomo Heavy Industries, Ltd. (TOKYO:6302) (“SHI”) today announces that Samsung Medical Center (“SMC”) in Seoul, Korea has commenced proton therapy*1 and the opening ceremony was held on May 3, 2016
May 25, 2016 15:30
Herbalife Sponsors Four National Olympic Committees at Rio 2016 Olympics and Paralympic Games
Global nutrition company Herbalife (NYSE: HLF) announced today it will be the official sponsor of the Costa Rican, Israeli, Italian and Vietnam National Olympic Committees all traveling to the Rio 201
May 25, 2016 11:00
IL-23 inhibitor risankizumab induces remission in Phase II study in patients with moderate-to-severe Crohn’s disease
Results were presented today from a proof-of-concept, Phase II, randomized, placebo-controlled study (NCT02031276) in Crohn’s disease with investigational biologic, risankizumab (formerly BI 655066),
May 24, 2016 15:15
Ferring Pharmaceuticals: World Bedwetting Day 2016 - New Evidence Confirms the Impact of Bedwetting on Children’s Daytime Functioning
World Bedwetting Day 2016 is marked today by the World Bedwetting Day Steering Committee, a new working group led by the International Children’s Continence Society (ICCS) and the European Society for
May 24, 2016 10:10
Samsung Bioepis' Biologics License Application for SB2 Infliximab Biosimilar Accepted by U.S. Food and Drug Administration
Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s Biologics License Application (BLA) for SB2, a biosimilar candidate ref
May 23, 2016 18:00
Scotland’s Patient Safety Programme Makes a Commitment to the Patient Safety Movement Foundation
The Patient Safety Movement Foundation (PSMF) announced today a commitment from Scotland’s national patient safety initiative, the Scottish Patient Safety Programme (SPSP). Launched in 2008, the SP
May 23, 2016 17:50
Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing
Boehringer Ingelheim and BioMed X announced today that they have established a new research team of outstanding scientists from around the world that will conduct research to identify novel approaches
May 20, 2016 14:00
Work It Out! Symbiotics® a Real Player in Muscle Recovery and Gut Health
Symbiotics®, a Naturade product, is the premier source of gastrointestinal health (GI) products that promote normal gut health and a healthy immune system which may enhance stamina and normal lean mus
25 per page50 per page75 per page100 per page